Abstract
Introduction
One-carbon metabolism (OCM) is a target of the chemotherapeutic agent capecitabine. We investigated OCM biomarker concentrations in relation to capecitabine-induced toxicities in patients with stage II-III colorectal cancer (CRC).
Method
Within a prospective cohort, 297 patients receiving adjuvant capecitabine-based chemotherapy were included. Pretreatment plasma concentrations of the OCM biomarkers folate, vitamin B2, vitamin B6, vitamin B12, total homocysteine, methionine, serine, and glycine were determined. We also investigated whether associations differed according to MTHFR C677T genotypes. Chemotherapy-induced toxicities were defined as toxicity-induced modifications of capecitabine treatment. To allow for inspection of shapes of the associations, restricted cubic splines (RCS) and Cox proportional hazards models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) adjusted for age and sex.
Results
In total, 156 (53%) patients experienced toxicity-induced modifications of capecitabine treatment. Folate was not associated with toxicities in the overall population. Higher folate concentrations were associated with a lower risk of toxicities in patients with MTHFR C677T CT/TT genotype (HRperdoubling 0.75, 95%CI 0.57-0.98) but not in patients with CC genotype (HRperdoubling 1.17, 95%CI 0.84-1.63). Higher concentrations of vitamin B2 were associated with a lower risk of toxicities (HRperdoubling 0.81 95%CI 0.67-0.99), whereas higher glycine concentrations were associated with a higher risk of toxicities (HRperdoubling 1.87, 95%CI 1.18-2.94). The association between vitamin B6 and vitamin B12 and toxicities appeared nonlinear. Homocysteine, methionine, and serine were not associated with toxicities.
Conclusions
Future studies investigating whether nutrition-guided optimization of OCM biomarkers will result in improved treatment tolerance are warranted.
One-carbon metabolism (OCM) is a target of the chemotherapeutic agent capecitabine. We investigated OCM biomarker concentrations in relation to capecitabine-induced toxicities in patients with stage II-III colorectal cancer (CRC).
Method
Within a prospective cohort, 297 patients receiving adjuvant capecitabine-based chemotherapy were included. Pretreatment plasma concentrations of the OCM biomarkers folate, vitamin B2, vitamin B6, vitamin B12, total homocysteine, methionine, serine, and glycine were determined. We also investigated whether associations differed according to MTHFR C677T genotypes. Chemotherapy-induced toxicities were defined as toxicity-induced modifications of capecitabine treatment. To allow for inspection of shapes of the associations, restricted cubic splines (RCS) and Cox proportional hazards models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) adjusted for age and sex.
Results
In total, 156 (53%) patients experienced toxicity-induced modifications of capecitabine treatment. Folate was not associated with toxicities in the overall population. Higher folate concentrations were associated with a lower risk of toxicities in patients with MTHFR C677T CT/TT genotype (HRperdoubling 0.75, 95%CI 0.57-0.98) but not in patients with CC genotype (HRperdoubling 1.17, 95%CI 0.84-1.63). Higher concentrations of vitamin B2 were associated with a lower risk of toxicities (HRperdoubling 0.81 95%CI 0.67-0.99), whereas higher glycine concentrations were associated with a higher risk of toxicities (HRperdoubling 1.87, 95%CI 1.18-2.94). The association between vitamin B6 and vitamin B12 and toxicities appeared nonlinear. Homocysteine, methionine, and serine were not associated with toxicities.
Conclusions
Future studies investigating whether nutrition-guided optimization of OCM biomarkers will result in improved treatment tolerance are warranted.
| Original language | English |
|---|---|
| Article number | 101457 |
| Number of pages | 11 |
| Journal | American Journal of Clinical Nutrition |
| Volume | 124 |
| Issue number | 3 |
| Early online date | 27 Jul 2026 |
| DOIs | |
| Publication status | Published - 1 Sept 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- one-carbon metabolism
- B-vitamins
- colorectal cancer
- chemotherapy
- toxicity
Fingerprint
Dive into the research topics of 'One-Carbon Metabolism and Chemotherapy-induced Toxicities in Patients with Stage II-III Colorectal Cancer: A Prospective Cohort Study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver